Biodefense definition
Examples of Biodefense in a sentence
Therefore, unless and until there is a Successful Biodefense Product directed to a particular Biodefense Target, any of the milestone payments made by Alnylam under this Section in connection with an Alnylam Product directed to such Biodefense Target shall be fully creditable against the repeated achievement of such milestone event by any other Alnylam Product directed to such Biodefense Target.
The milestone payments described above shall be payable only once in relation to each Alnylam Royalty Product directed to a Biodefense Target that achieves First Commercial Sale in a Major Market (each, a “Successful Biodefense Product”).
Intrexon recognizes that Soligenix’s intention is for the Melioidosis Program to be supported predominantly by Government Funding through the Biodefense Sector and/or by non-profit agencies as an emerging infectious disease.
Therefore, unless and until there is a Successful Biodefense Product directed to a particular Biodefense Target, any of the milestone payments made by ALNYLAM under this Section in connection with a Licensed Product directed to such Biodefense Target shall be fully creditable against the repeated achievement of such milestone event by any other Licensed Product directed to such Biodefense Target.
The license granted with respect to ALNYLAM Development Products under PROTIVA Patent Rights will be royalty-bearing with respect to ALNYLAM Development Products that are, with respect to ALNYLAM, Licensed Products (whether or not the same are directed to Biodefense Targets).
The milestone payments described above shall be payable only once in relation to each Licensed Product directed to a Biodefense Target that achieves First Commercial Sale in a Major Market (each, a “Successful Biodefense Product”).
Seller’s representative is a shareholder of record and current Chairman and CEO of U.S. Biodefense, Inc.
Attn: D▇▇▇▇ ▇▇▇▇▇▇▇▇▇/COO 3▇▇ ▇▇▇▇▇ ▇▇., ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇▇▇▇ US Biodefense, Inc.
These payments will be made only once per Licensed Product per Biodefense Indications within the Field.
Napo received a grant of $597,000 in 2006 from the Center for Scientific Review of the National Institutes of Health, in response to a RFA – A1-05-19 the Cooperative Research Partnership for Biodefense, to support Napo’s project entitled, “Development of Crofelemer to treat Vibrio Cholarae”, for the development of the enteric-coated formulation used in Napo’s cholera studies.